BIOMAT Database Logo BIOMAT Database Logo

[Corticosteroid therapy in myasthenia gravis: preliminary considerations on the long-term treatment with prednisone]. 1974

F Cornelio, and T Caraceni, and S Negri

UI MeSH Term Description Entries
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

F Cornelio, and T Caraceni, and S Negri
Long-term corticosteroid treatment of myasthenia gravis.
January 1987, Annals of the New York Academy of Sciences,
F Cornelio, and T Caraceni, and S Negri
Long-term results of corticosteroid therapy in patients with myasthenia gravis.
January 1992, European neurology,
F Cornelio, and T Caraceni, and S Negri
Long-term treatment of myasthenia gravis with alternate-day prednisone. Report on 15 patients.
January 1974, European neurology,
F Cornelio, and T Caraceni, and S Negri
[Myasthenia gravis--treatment with prednisone].
November 1982, Ceskoslovenska neurologie a neurochirurgie,
F Cornelio, and T Caraceni, and S Negri
Long-term prednisone followed by thymectomy in myasthenia gravis.
January 1976, Annals of the New York Academy of Sciences,
F Cornelio, and T Caraceni, and S Negri
Severe occult juvenile myasthenia gravis responsive to long-term corticosteroid therapy.
January 1968, Transactions of the American Neurological Association,
F Cornelio, and T Caraceni, and S Negri
Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients.
March 1984, Annals of neurology,
F Cornelio, and T Caraceni, and S Negri
Treatment of myasthenia gravis with prednisone.
April 1972, Lancet (London, England),
F Cornelio, and T Caraceni, and S Negri
[Myasthenia gravis (3). Corticosteroid therapy of myasthenia gravis].
October 1978, Lakartidningen,
F Cornelio, and T Caraceni, and S Negri
[Long-term treatment with 7S immunoglobulins in myasthenia gravis. Preliminary clinical results].
April 1996, Der Nervenarzt,
Copied contents to your clipboard!